Cambridge Nutritional Scienc (CNSL.L) traded flat 0 % during a 24 hours period ending at 07:23 AM Central Europe on Tuesday 27th. One Cambridge Nutritional Scienc stock can currently be bought for about GBX 1.55 on popular exchanges. Current supply of Cambridge Nutritional Scienc stocks is 2.4 mn. Cambridge Nutritional Scienc has a current market capitalization of GBX 4.7 mn and approximately GBX 2 k worth of Cambridge Nutritional Scienc was traded on exchanges in the last 24 hours. Since last month end, Cambridge Nutritional Scienc has traded 0 % flat. Simple moving average of last 200 days is at GBX 1.84. The highest price of past 52 weeks was recorded at GBX 2.8 on 11/04/2025. 52 weeks low was at GBX 1.25 on 09/08/2026.
Here is how related stocks have performed in the past 24 hours:
Ironveld (IRON.L) traded flat 0 % and now trades at GBX 0.02. Current market capitalisation for Ironveld is GBX 5.3 mn.
Anglesey Mining (AYM.L) traded flat 0 % and now trades at GBX 5.75. Current market capitalisation for Anglesey Mining is GBX 4.9 mn. Current price/earnings ratio for Anglesey Mining is 2.26.
Primorus Investments (PRIM.L) traded flat 0 % and now trades at GBX 3.4. Primorus Investments has a market capitalisation of GBX 5 mn. Current price/earnings ratio for Primorus Investments is 2.78.
Gfinity (GFIN.L) traded up 2.04 % and now trades at GBX 0.05. Current market capitalisation for Gfinity is GBX 5.4 mn.
Adalan Ventures (ZAIM.L) traded flat 0 % and now trades at GBX 0.04. Current market capitalisation for Adalan Ventures is GBX 4.7 mn.
About Cambridge Nutritional Scienc
Cambridge Nutritional Sciences PLC is a company that specializes in the research, development, production, and distribution of nutritional products and services for the healthcare industry. The company operates through its three segments: Nutrition and Metabolism, Digestive Health, and Neuroscience. The Nutrition and Metabolism segment focuses on developing and providing innovative nutritional products and technologies to address various health issues related to metabolism and nutrition. This segment’s key product is Metabolic Balance, an evidence-based metabolic nutrition program that helps individuals manage their weight and overall health. The Digestive Health segment is committed to providing high-quality, innovative solutions for gastrointestinal health issues. This segment offers a range of probiotics, prebiotics, and synbiotics, along with other dietary supplements, to support gut health. The Neuroscience segment is dedicated to developing novel neuroscience-based products and technologies to address cognitive and mental health issues. This segment’s primary focus is on developing and commercializing Omega-3 fatty acid-based formulations for cognitive and brain health. Cambridge Nutritional Sciences PLC’s mission is to transform the way people eat and experience health by providing innovative, high-quality nutritional products and services that are accessible, affordable, and effective. The company’s products are available in over 40 countries worldwide, and the company has its main office located in Cambridge, United Kingdom.